cardiovascular drugs Flashcards
what is atherosclerosis
buildup of fatty plaque, loss of elasticity of walls of arteries, narrow, thrombi
cholesterol
essential for life but too much LDL is bad
lipids
- LSL is greatest contributor to ASCVD, storage, bad delivery
- VLDL/triglyceride: deliver and store
- HDL (removal): healthy/good, promote removal
ASCVD risk assessment
- screen adults and pediatrics
- race
- advancing age
- HTN
- cigarette smoking
- diabetes (risk is equivalent)
- low HDL
therapeutic lifestyle changes
- exercise
- diet
- smoking cessation
- weight control
dyslipidemia drugs
- HMG-CoA reductase inhibitors
- bile salt sequestrant
- cholesterol absorption inhibitor
- fibrates
HMG-CoA reductase inhibitor prototype
atorvastatin (Lipitor)
atorvastatin purpose
- reduce LDL
- increases HDL
- reduces triglycerides
atorvastatin MoA
inhibits HMG-CoA reductase and increased LDL receptor sites
atorvastatin therapeutic uses
- lowers events related to ASCVD
- heart failure
- stroke/MI/death
atorvastatin side effects
- hepatotoxicity
- myopathy
- GI upset
- memory loss
- cat x, do not give to pregnant ppl
atorvastatin nursing interventions/education
- liver function tests before and during therapy
- jaundice
- avoid alcohol
- monitor CK levels and for signs of muscle weakness
- do not give to ppl with hepatitis
- use cautiously in older adults
- administer at bed time
bile salt sequestrant prototype
colesevelam or cholestyramine
colesevelam or cholestyramine purpose
decreases LDL cholesterol
colesevelam or cholestyramine MoA
binds to bile salts and prevents their reabsorption
colesevelam or cholestyramine adverse effects
constipation
colesevelam or cholestyramine nursing interventions/education
- dose 1 hour before or 4 hours after thiazides, digoxin, and warfarin
- cholestyramine decrease uptake of fat-soluble vitamins (ADEK)
- increase fluids and water
- take with food and full glass of water
cholesterol absorption inhibitors prototype
ezetimibe
ezetimibe purpose
reduction of total cholesterol, reduction of LDL
ezetimibe MoA
- inhibits dietary cholesterol absorption in small intestines
- inhibits reabsorption of cholesterol in bile
- monotherapy or combined with a statin
ezetimibe adverse effects
- hepatotoxicity
- muscle pain
ezetimibe nursing interventions/education
- monitor liver function tests, signs of dysfunction (jaundice)
- monitor CK
- avoid alcohol
fibrates prototype
gemfibrozil
gemfibrozil purpose
to decrease triglyceride levels and increase HDL levels
gemfibrozil therapeutic uses
- reduction of VLDL and increase levels of HDL
gemfibrozil MoA
decrease TG production and transport
gemfibrozil things to keep in mind
- no effect on LDL
- no proof of ASCVD mortality reduction
- many side effect: 3rd line drug of choice
gemfibrozil adverse effects
- rash
- gi distress
- gallstones
- myopathy
- hepatotoxicity
gemfibrozil nursing interventions/education
- watch for signs of gallbladder disease (RUQ)
- monitor CK levels and watch for muscle weakness
- monitor liver function tests
- increases risk for bleeding when coumadin
- proceed with caution if also dosed with statins
- take 30 minutes before breakfast and dinner
hemodynamics review
- circulatory system (veins, capillaries, arteries)
- pulmonary and systemic
- cardiac output=HR x stroke volume
- stroke volume=preload, afterload, and contractility